← back to search

Philipp Jansen

University of Duisburg-Essen · DE
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, and AI in cancer detection.
h-index
21
citations
3,034
works
79
NIH funding
primary concept
email

Recent publications

Early versus late response to PD-1-based immunotherapy in metastatic melanoma
European Journal of Cancer 2024cited by 7position: middledoi
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
European Journal of Cancer 2024cited by 4position: firstdoi
Characterisation and outcome of RAC1 mutated melanoma
European Journal of Cancer 2023cited by 14position: middledoi
Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide Images
Journal of Fungi 2022cited by 37position: firstdoi
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
European Journal of Cancer 2022cited by 24position: middledoi
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
International Journal of Cancer 2022cited by 6position: middledoi
Clinical and pathological characteristics of familial melanoma with germline <scp><i>TERT</i></scp> promoter variants
Pigment Cell & Melanoma Research 2022cited by 5position: middledoi
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
Cancers 2022cited by 1position: middledoi
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
European Journal of Cancer 2021cited by 31position: middledoi
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
European Journal of Cancer 2021cited by 19position: middledoi
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
European Journal of Cancer 2021cited by 9position: middledoi
Artificial Intelligence and Its Effect on Dermatologists’ Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study
Journal of Medical Internet Research 2020cited by 88position: middledoi
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
Frontiers in Immunology 2020cited by 38position: middledoi
Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia: a prospective study
World Journal of Surgical Oncology 2020cited by 10position: firstdoi
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
European Journal of Cancer 2019cited by 573position: middledoi
Superior skin cancer classification by the combination of human and artificial intelligence
European Journal of Cancer 2019cited by 352position: middledoi
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task
European Journal of Cancer 2019cited by 298position: middledoi
Pathologist-level classification of histopathological melanoma images with deep neural networks
European Journal of Cancer 2019cited by 231position: middledoi
Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
European Journal of Cancer 2019cited by 214position: middledoi
Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
Science Immunology 2019cited by 136position: middledoi
Clinical and genetic analysis of melanomas arising in acral sites
European Journal of Cancer 2019cited by 43position: middledoi
The prognostic value of sentinel lymph nodes on distant metastasis–free survival in patients with high-risk squamous cell carcinoma
European Journal of Cancer 2019cited by 14position: firstdoi
Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi
Cancers 2019cited by 12position: firstdoi
Postsurgical Treatment of Split Skin Graft Donor Sites in Dermatological Departments
The International Journal of Lower Extremity Wounds 2018cited by 7position: firstdoi
Laser-Assisted Delivery Of Cold Atmospheric Plasma In Unresectable Cutaneous Metastasis In Melanoma Patients
Clinical Plasma Medicine 2018cited by 2position: firstdoi
Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study
JMIR mhealth and uhealth 2017cited by 39position: middledoi
A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial
Journal of Medical Internet Research 2017cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori15 papers (2017–2022)Joachim Klode · Essen University Hospital10 papers (2017–2020)Titus J. Brinker · National Center for Tumor Diseases8 papers (2017–2020)Ingo Stoffels · Kliniken Essen-Mitte7 papers (2017–2020)Klaus Griewank · Düsseldorf University Hospital7 papers (2019–2022)Antje Sucker · German Marine Research Consortium7 papers (2019–2022)Anne Zaremba · University of Manitoba6 papers (2019–2022)Eva Hadaschik · Essen University Hospital6 papers (2019–2022)Inga Möller · Düsseldorf University Hospital6 papers (2019–2022)Rajmohan Murali · Faculty of Media5 papers (2019–2022)Lisa Zimmer · German Marine Research Consortium5 papers (2019–2022)Annette Paschen · University Hospital Heidelberg5 papers (2019–2022)Elisabeth Livingstone · German Cancer Research Center5 papers (2019–2022)Ioana Cosgarea · NIHR Newcastle Biomedical Research Centre4 papers (2017–2021)Julia Kretz · Roche (Switzerland)4 papers (2021–2022)Cindy Franklin · University of Cologne4 papers (2019–2020)Nadine Stadtler · German Cancer Research Center3 papers (2022–2022)Manuel Philip · German Cancer Research Center3 papers (2021–2022)Susanne Horn · Helmholtz Zentrum München3 papers (2021–2022)Maximilian Petri · Medizinische Hochschule Hannover2 papers (2019–2020)